NDC 68025-089

RELEXXII

Methylphyenidate Hydrochloride Extended-release

RELEXXII is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Vertical Pharmaceuticals, Llc. The primary component is Methylphenidate Hydrochloride.

• Product ID: 68025-089_ff11a57c-30b9-4b83-bc95-68272d324923
• NDC: 68025-089
• Product Type: Human Prescription Drug
• Proprietary Name: RELEXXII
• Generic Name: Methylphyenidate Hydrochloride Extended-release
• Dosage Form: Tablet, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2022-06-23
• Marketing Category: NDA /
• Application Number: NDA216117
• Labeler Name: Vertical Pharmaceuticals, LLC
• Substance Name: METHYLPHENIDATE HYDROCHLORIDE
• Active Ingredient Strength: 63 mg/1
• Pharm Classes: Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
• DEA Schedule: CII
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 68025-089-10

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-089-10)

• Marketing Start Date: 2022-06-23
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "RELEXXII" or generic name "Methylphyenidate Hydrochloride Extended-release"

NDC	Brand Name	Generic Name
68025-084	RELEXXII	methylphenidate hydrochloride
68025-088	RELEXXII	methylphyenidate hydrochloride extended-release
68025-089	RELEXXII	methylphyenidate hydrochloride extended-release